{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:06:21Z","timestamp":1762938381901,"version":"3.45.0"},"reference-count":39,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"European Union\u2019s Horizon 2020 research and innovation programme","award":["874735 (VEO)"],"award-info":[{"award-number":["874735 (VEO)"]}]},{"name":"National Public Investment Program of the Ministry of Development and Investment\/General Secretariat for Research and Technology","award":["2020\u2211\u039501300001"],"award-info":[{"award-number":["2020\u2211\u039501300001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epidemiologia"],"abstract":"<jats:p>Background\/Objectives: Since its emergence in late 2019, SARS-CoV-2 has demonstrated remarkable genetic diversity driven by mutations and recombination events that shaped the course of the COVID-19 pandemic. Continuous genomic monitoring is essential to track viral evolution, assess the spread of variants of concern (VOCs), and inform public health strategies. The present study aimed to characterize the molecular epidemiology of SARS-CoV-2 in northern Greece from the first national case in February 2020 through early 2025. Methods: A total of 66 respiratory samples collected from hospitalized patients across Northern Greece were subjected to whole-genome sequencing using Oxford Nanopore Technologies\u2019 MinION Mk1C platform and the ARTIC protocol. Sequences were analyzed with PANGO, Nextclade, and GISAID nomenclature systems for lineage and clade assignment, and the WHO nomenclature for VOCs. Results: Across 66 genomes, 34 PANGO lineages were identified. Early introductions included B.1 (2\/66), B.1.177 (3\/66), and B.1.258 (1\/66). Alpha (5\/66) and Beta (5\/66) circulated in February\u2013June 2021. Delta (AY.43) was detected in early 2022 (2\/66; Jan\u2013Feb) but was rapidly displaced by Omicron and reached 100% of the sequences by May 2022. Omicron diversified into BA.1\/BA.1.1 (3\/66), BA.2 (6\/66), BA.4\/BA.5 (14\/66), BF.5 (1\/66), EG.5 (1\/66; designated a WHO Variant of Interest in 2023), JN.1 (4\/66; globally dominant lineage prompting vaccine updates in 2024\u20132025), KS.1 (2\/66; together with KS.1.1 are recognized PANGO lineages that were tracked internationally but remained less prevalent), KP.3 (5\/66; together with KP.3.1.1, prominent \u201cFLiRT\u201d descendants circulating in 2024), and recombinants XDK, XDD, and XEC (5\/66), reported by their PANGO names in accordance with the WHO\u2019s current framework, which reserves Greek letters only for newly designated VOCs. Conclusions: This five-year genomic analysis provides an insight into the continuous evolution of SARS-CoV-2 in northern Greece. The findings underscore the importance of sustained genomic surveillance, integrated with epidemiological data, to detect emerging variants, monitor recombination, and strengthen preparedness for future coronavirus threats.<\/jats:p>","DOI":"10.3390\/epidemiologia6040078","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T08:58:47Z","timestamp":1762937927000},"page":"78","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular Epidemiology of SARS-CoV-2 in Northern Greece from the Index Case up to Early 2025 Using Nanopore Sequencing"],"prefix":"10.3390","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8750-513X","authenticated-orcid":false,"given":"Georgios","family":"Meletis","sequence":"first","affiliation":[{"name":"Laboratory of Microbiology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2249-2443","authenticated-orcid":false,"given":"Styliani","family":"Pappa","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7215-106X","authenticated-orcid":false,"given":"Georgia","family":"Gioula","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4052-8550","authenticated-orcid":false,"given":"Maria","family":"Exindari","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Christoforidi","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6643-3322","authenticated-orcid":false,"given":"Anna","family":"Papa","sequence":"additional","affiliation":[{"name":"Laboratory of Microbiology, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"ref_1","unstructured":"(2025, September 02). Worldometer-Coronavirus. Available online: https:\/\/www.worldometers.info\/coronavirus."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/dx-2021-0149","article-title":"Updated picture of SARS-CoV-2 variants and mutations","volume":"9","author":"Lippi","year":"2021","journal-title":"Diagnosis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/08830185.2022.2079642","article-title":"SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies","volume":"42","author":"Gong","year":"2023","journal-title":"Int. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41232-020-00126-7","article-title":"Genome evolution of SARS-CoV-2 and its virological characteristics","volume":"40","author":"Nakagawa","year":"2020","journal-title":"Inflamm. Regen."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","article-title":"Nextstrain: Real-time tracking of pathogen evolution","volume":"34","author":"Hadfield","year":"2018","journal-title":"Bioinformatics"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41564-020-0770-5","article-title":"A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology","volume":"5","author":"Rambaut","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"veab064","DOI":"10.1093\/ve\/veab064","article-title":"Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool","volume":"7","author":"Scher","year":"2021","journal-title":"Virus Evol."},{"key":"ref_9","first-page":"328","article-title":"A comparative overview of SARS-CoV-2 and its variants of concern","volume":"30","author":"Ahmad","year":"2022","journal-title":"Infez. Med."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Scovino, A.M., Dahab, E.C., Vieira, G.F., Freire-de-Lima, L., Freire-de-Lima, C.G., and Morrot, A. (2022). SARS-CoV-2\u2019s Variants of Concern: A brief characterization. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.834098"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bj.2022.04.006","article-title":"SARS-CoV-2 variants\u2013Evolution, spike protein, and vaccines","volume":"45","author":"Chen","year":"2022","journal-title":"Biomed. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2000603","DOI":"10.2807\/1560-7917.ES.2020.25.13.2000305","article-title":"Whole Genome and Phylogenetic Analysis of Two SARS-CoV-2 Strains Isolated in Italy in January and February 2020","volume":"25","author":"Stefanelli","year":"2020","journal-title":"Euro Surveill."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102051","DOI":"10.1016\/j.tmaid.2021.102051","article-title":"Coronavirus disease 2019 pandemic in Greece, February 26\u2013May 3, 2020: The first wave","volume":"41","author":"Maltezou","year":"2021","journal-title":"Travel Med. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Di Giallonardo, F., Duchene, S., Puglia, I., Curini, V., Profeta, F., Camm\u00e0, C., Marcacci, M., Calistri, P., Holmes, E.C., and Lorusso, A. (2020). Genomic Epidemiology of the First Wave of SARS-CoV-2 in Italy. Viruses, 12.","DOI":"10.3390\/v12121438"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41586-020-2895-3","article-title":"Spike Mutation D614G Alters SARS-CoV-2 Fitness","volume":"592","author":"Plante","year":"2021","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-021-03677-y","article-title":"Spread of a SARS-CoV-2 Variant through Europe in the Summer of 2020","volume":"595","author":"Hodcroft","year":"2021","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s11262-021-01866-5","article-title":"A SARS-CoV-2 Mutant from B.1.258 Lineage with \u2206H69\/\u2206V70 Deletion in the Spike Protein Circulating in Central Europe in the Fall 2020","volume":"57","author":"Paul","year":"2021","journal-title":"Virus Genes"},{"key":"ref_19","first-page":"285","article-title":"Genomic and Epidemiological Surveillance of SARS-CoV-2 Epidemic in Northwestern Greece","volume":"69","author":"Sakaloglou","year":"2024","journal-title":"Acta Microbiol. Hell."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"eabg3055","DOI":"10.1126\/science.abg3055","article-title":"Estimated Transmissibility and Impact of SARS-CoV-2 Lineage B.1.1.7 in England","volume":"372","author":"Davies","year":"2021","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ijid.2021.03.005","article-title":"Infection Sustained by Lineage B.1.1.7 of SARS-CoV-2 Is Characterized by Longer Persistence and Higher Viral RNA Loads in Nasopharyngeal Swabs","volume":"105","author":"Calistri","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2100509","DOI":"10.2807\/1560-7917.ES.2021.26.24.2100509","article-title":"Increased Transmissibility and Global Spread of SARS-CoV-2 Variants of Concern as at June 2021","volume":"26","author":"Campbell","year":"2021","journal-title":"Euro Surveill."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-021-03402-9","article-title":"Detection of a SARS-CoV-2 Variant of Concern in South Africa","volume":"592","author":"Tegally","year":"2021","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.3201\/eid2712.211631","article-title":"Incidence Trends for SARS-CoV-2 Alpha and Beta Variants, Finland, Spring 2021","volume":"27","author":"Kant","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1473-3099(21)00475-8","article-title":"Hospital admission and emergency care attendance risk for SARS-CoV-2 Delta (B.1.617.2) compared with Alpha (B.1.1.7): A cohort study","volume":"22","author":"Twohig","year":"2022","journal-title":"Lancet Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Meletis, G., Tychala, A., Ntritsos, G., Verrou, E., Savvidou, F., Dermitzakis, I., Chatzidimitriou, A., Gkeka, I., Fyntanidou, B., and Gkarmiri, S. (2023). Variant-Related Differences in Laboratory Biomarkers among Patients Affected with Alpha, Delta and Omicron: A Retrospective Whole Viral Genome Sequencing and Hospital-Setting Cohort Study. Biomedicines, 11.","DOI":"10.3390\/biomedicines11041143"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41586-022-04411-y","article-title":"Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in Southern Africa","volume":"603","author":"Viana","year":"2022","journal-title":"Nature"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(22)00462-7","article-title":"Comparative analysis of the risks of hospitalisation and death associated with Omicron (B.1.1.529) and Delta (B.1.617.2) variants in England: A cohort study","volume":"399","author":"Nyberg","year":"2022","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Catal\u00e0, M., Coma, E., Alonso, C., Andr\u00e9s, E., Blanco, I., Ant\u00f3n, A., Bordoy, M., Cardona, G., Fina, L., and Martr\u00f3, E. (2022). Transmissibility, Hospitalization, and Intensive Care Admissions Due to Omicron Compared to Delta Variants of SARS-CoV-2 in Catalonia: A Cohort Study and Ecological Analysis. Front. Public Health, 10.","DOI":"10.3389\/fpubh.2022.961030"},{"key":"ref_30","first-page":"572","article-title":"Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution","volume":"615","author":"Cao","year":"2023","journal-title":"Nature"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"veab059","DOI":"10.1093\/ve\/veab059","article-title":"Recombinant SARS-CoV-2 genomes circulated at low levels over the first year of the pandemic","volume":"7","author":"VanInsberghe","year":"2021","journal-title":"Virus Evol."},{"key":"ref_32","unstructured":"World Health Organization (2023). Statement on EG.5 Initial Risk Evaluation (IRE), WHO. Available online: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/09082023eg.5_ire_final.pdf."},{"key":"ref_33","unstructured":"World Health Organization (2025). COVID-19\u2014Global Situation, WHO. Available online: https:\/\/www.who.int\/emergencies\/disease-outbreak-news\/item\/2025-DON572."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/hcs2.110","article-title":"Emergence of SARS-CoV-2 variants KP.2 and KP.3 sparks concerns: What should we do?","volume":"3","author":"Shanmugaraj","year":"2024","journal-title":"Health Care Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1038\/nprot.2017.066","article-title":"Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples","volume":"12","author":"Quick","year":"2017","journal-title":"Nat. Protoc."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Tyler, A.D., Mataseje, L., Urfano, C.J., Schmidt, L., Antonation, K.S., Mulvey, M.R., and Corbett, C.R. (2018). Evaluation of Oxford Nanopore\u2019s MinION sequencing device for microbial whole genome sequencing applications. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-29334-5"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"veaa075","DOI":"10.1093\/ve\/veaa075","article-title":"Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterization","volume":"6","author":"Charre","year":"2020","journal-title":"Virus. Evol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.gpb.2016.05.004","article-title":"Oxford Nanopore MinION sequencing and genome assembly","volume":"14","author":"Lu","year":"2016","journal-title":"Genom. Proteom. Bioinform."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Meletis, G., Tychala, A., Gkeka, I., Gkotzia, A., Triantafyllou, A., Pappa, S., Exindari, M., Gioula, G., Papa, A., and Skoura, L. (2022). Clinical Performance Evaluation of the NeuMoDx Flu A-B\/RSV\/SARS-CoV-2 Vantage Assay. Diagnostics, 12.","DOI":"10.3390\/diagnostics12123201"}],"container-title":["Epidemiologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2673-3986\/6\/4\/78\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:03:36Z","timestamp":1762938216000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2673-3986\/6\/4\/78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["epidemiologia6040078"],"URL":"https:\/\/doi.org\/10.3390\/epidemiologia6040078","relation":{},"ISSN":["2673-3986"],"issn-type":[{"value":"2673-3986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]}}}